Home » Topics » BioWorld Science

BioWorld Science
RSS

NIAID files IND application for phase IIa study of next-generation pertussis vaccine BPZE-1

May 17, 2018

Sumitomo Dainippon updates pipeline activities of fourth quarter of fiscal 2017

May 17, 2018

Cipher acquires Correvio's Canadian business portfolio

May 17, 2018

Rexahn advances phase IIa study of RX-3117 and Abraxane in metastatic pancreatic cancer

May 16, 2018

BioLamina and Novo Nordisk partner to develop novel stem cell-based therapies based on Biolaminins

May 16, 2018

Pivotal study of Dupixent in moderate to severe atopic dermatitis in adolescents meets key endpoints

May 16, 2018

V21-DOS47 immunoconjugate shows promising antitumoral activity in vivo

May 16, 2018

FDA approves Truvada to reduce risk of HIV-1 infection in adolescents

May 16, 2018

Otsuka highlights progress of first quarter 2018

May 16, 2018

Inovio reports new data from phase I study of HIV vaccine Pennvax-GP

May 16, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...